Sign in

CIK 0001612042 · Large accelerated filer

Ascendis Pharma A/S

Sign in to watch
Ticker
ASND
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Denmark
Entity type
other
Phone
45 70 22 22 44
Business address
TUBORG BOULEVARD 12, HELLERUP, Denmark
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market sale SVP & PAO sold 3,000 shares at $270.19 ($810,570)
  3. 4 Open-market sale Director sold 236 shares at $264.13 ($62,335)
  4. 4 Open-market buy Director bought 2,000 shares at an average $246.33 ($492,654)
  5. 4 Open-market buy EVP & Chief Financial Officer bought 100 shares at $219.00 ($21,900)
  6. 4 Open-market buy Director bought 500 shares at an average $223.12 ($111,562)
  7. 4 Open-market buy EVP & Chief Financial Officer bought 250 shares at $223.32 ($55,830)
  8. 3/A Insider 3/A
  9. 4 Open-market buy Director bought 400 shares at an average $237.80 ($95,121)
  10. 4 Open-market sale See Remarks sold 19,460 shares at $238.49 ($4,641,021)
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 1 of 2 · 25 filings